Brand Name: Ricovir-L
Generic Name: Lamivudine and Tenofovir disoproxil fumarate
Dosage Form: Tablet
Composition: Lamivudine (300mg) and Tenofovir disoproxil fumarate (300mg)
Packaging: 30 tablets (30 / strip)
Storage: Store at room temperature.
Ricovir-L (Lamivudine and Tenofovir disoproxil fumarate) tablet is a combination of two antiretroviral medicines. It belongs to a class of medication known as nucleoside reverse transcriptase inhibitors (NRTIs). This medication is used in the treatment of HIV (human immunodeficiency virus) infection. This medication helps to reduce the amount of HIV in your body and boost your immune system to fight against infection. It is important to take Ricovir-L tablets as prescribed by your doctor. It is advised not to change your regular dosing schedule without taking suggestions from your doctor. The recommended dose of Efamat medicine is decided by a doctor according to your previous medical condition and response to the treatment.
Lamivudine (Ricovir L):- It is a nucleoside reverse transcriptase inhibitor (NRTI) with activity against Human Immunodeficiency Virus Type 1 (HIV-1) and Hepatitis B (HBV) to disrupt viral DNA synthesis. Lamivudine can form active metabolites when phosphorylated, that compete for incorporation into viral DNA. Via DNA incorporation, lamivudine metabolites inhibit the activity of the HIV reverse transcriptase enzyme and then act as a chain terminator of DNA synthesis.
Tenofovir disoproxil fumarate (Ricovir L): It is an acyclic nucleoside phosphonate diester analog of adenosine monophosphate. This compound requires initial diester hydrolysis for conversion to tenofovir and subsequent phosphorylations by cellular enzymes to form tenofovir diphosphate. Tenofovir diphosphate works to inhibit the activity of HIV-1 RT by competing with the natural substrate deoxyadenosine 5′-triphosphate and, after incorporation into DNA, by DNA chain termination. It is known to be a weak inhibitor of mammalian DNA polymerases alpha, beta, and mitochondrial DNA polymerase gamma.
Ricovir-L tablet is a combination of two anti-HIV medicines: Lamivudine and Tenofovir disoproxil fumarate. This medication is not a permanent cure for HIV infection. It prevents the virus from multiplying and also increases the CD4 cell (white blood cells that protect against infection) count in your blood. Close monitoring of liver function and kidney function is required during treatment with this medication. Do not take Ricovir L tablet in the wrong way as it may lead to some severe side effects. If you experience any symptoms while receiving this medicine, inform your doctor immediately.
Ricovir-L tablets can interact with other medications and it may increase the risk for side effects. Don’t forget to disclose and discuss your previous medical history with the doctor.
Do not take this medicine if you are allergic to Lamivudine and Tenofovir disoproxil fumarate.
Ricovir-L (Lamivudine and Tenofovir disoproxil fumarate) medicine is not recommended in patients known to be hypersensitive.
- This medication is not recommended in patients with severe kidney disease.
This medicine may cause some side effects. Discuss the risks and benefits of the Ricovir-L tablets with the doctor before starting the treatment.
Common side effects
Note - immediately contact your health care provider if any side effects occur.
Take this medicine as prescribed by your doctor. Make sure to not skip or stop your regular dosing schedule.
Before starting treatment with Ricovir-L medicine, please inform your doctor about your previous medical history. If you experience any signs and symptoms while receiving this medication, do not ignore those symptoms because it may lead to higher risk.
Children and adolescents
Warnings for female
Ricovir-L tablets may increase the risk of immune reconstitution syndrome.
Inform your doctor if you experience any side effects like- nausea, insomnia, fever, sore throat, headache, allergic reaction, anxiety, etc.
This medication may increase the risk of pancreatitis in some patients.
Ricovir-L tablets increase the risk of lactic acidosis.
Close monitoring of body fat distribution and body weight is required during treatment with this medicine.
Do not drive or operate heavy machinery.
Do not crush or break the tablet.
Not safe for pregnant women.
Do not breastfeed while receiving this medication.
Q1. What is Ricovir-L (Lamivudine and Tenofovir disoproxil fumarate)?
Ans. Ricovir-L tablet is a combination of two antiretroviral medicines. It is used in the treatment of HIV (human immunodeficiency virus) infection. This medicine boosts your body’s immune system to fight against infection.
Q2. What are the side effects?
Ans. Some common side effects are:- dizziness, nausea, fever, diarrhea, insomnia, headache, loss of appetite, chest pain, allergic reaction, etc.
Q3. In what strength is it available?
Ans. It is available in the strength of 300mg/300mg.
Q4. How to take this medicine?
Ans. It is important to take this medicine as prescribed by your doctor.
Q5. Can I drive after taking this medicine?
Ans. This medicine may affect your vision and your ability to concentrate.
Q6.How does Ricovir L work?
Ans. This medication prevents the virus from multiplying and also increases the CD4 cell (white blood cells that protect against infection) count in your blood.
Q7. What should I avoid while receiving this medication?
Ans. Follow your doctor’s advice about any restrictions on food and other activities.
Q8. What happens if I miss a dose?
Ans. If you miss a scheduled dose of Ricovir-L tablets, contact your doctor immediately.
Q9. Can I take this medicine during pregnancy?
Ans. This medicine is not recommended during pregnancy.
Q10. Does this medicine affect liver function?
Ans. Please consult your doctor before consuming this drug.
Q11. What are the storage conditions?
Ans. Store this medicine at room temperature.
Q12. Can I take this medicine during breastfeeding?
Ans. This medicine is not recommended in breastfeeding unless it is necessary.
Q13. Can I consume alcohol while receiving this medicine?
Ans. Please consult your doctor before consuming alcohol.